vs

Side-by-side financial comparison of DORCHESTER MINERALS, L.P. (DMLP) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.

DORCHESTER MINERALS, L.P. is the larger business by last-quarter revenue ($41.9M vs $40.7M, roughly 1.0× PETMED EXPRESS INC). DORCHESTER MINERALS, L.P. runs the higher net margin — 38.7% vs -26.0%, a 64.6% gap on every dollar of revenue. On growth, DORCHESTER MINERALS, L.P. posted the faster year-over-year revenue change (5.4% vs -23.3%). Over the past eight quarters, DORCHESTER MINERALS, L.P.'s revenue compounded faster (16.2% CAGR vs -20.9%).

Dorchester Minerals, L.P. is a publicly traded master limited partnership based in the United States. It acquires, owns, and manages a diversified portfolio of royalty interests, net profit interests, and mineral properties associated with oil, natural gas, and natural gas liquids production across key onshore U.S. energy basins, delivering stable cash flow returns to its unitholders.

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

DMLP vs PETS — Head-to-Head

Bigger by revenue
DMLP
DMLP
1.0× larger
DMLP
$41.9M
$40.7M
PETS
Growing faster (revenue YoY)
DMLP
DMLP
+28.7% gap
DMLP
5.4%
-23.3%
PETS
Higher net margin
DMLP
DMLP
64.6% more per $
DMLP
38.7%
-26.0%
PETS
Faster 2-yr revenue CAGR
DMLP
DMLP
Annualised
DMLP
16.2%
-20.9%
PETS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
DMLP
DMLP
PETS
PETS
Revenue
$41.9M
$40.7M
Net Profit
$16.2M
$-10.6M
Gross Margin
23.3%
Operating Margin
-25.7%
Net Margin
38.7%
-26.0%
Revenue YoY
5.4%
-23.3%
Net Profit YoY
13.7%
-1392.6%
EPS (diluted)
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DMLP
DMLP
PETS
PETS
Q4 25
$41.9M
$40.7M
Q3 25
$35.4M
$44.4M
Q2 25
$32.4M
$51.2M
Q1 25
$43.2M
$50.8M
Q4 24
$39.7M
$52.0M
Q3 24
$53.5M
$58.0M
Q2 24
$37.4M
$66.2M
Q1 24
$31.0M
$65.1M
Net Profit
DMLP
DMLP
PETS
PETS
Q4 25
$16.2M
$-10.6M
Q3 25
$11.2M
$-8.5M
Q2 25
$12.3M
$-34.2M
Q1 25
$17.6M
$-11.6M
Q4 24
$14.2M
$-707.0K
Q3 24
$36.4M
$2.3M
Q2 24
$23.6M
$3.8M
Q1 24
$18.2M
$-5.0M
Gross Margin
DMLP
DMLP
PETS
PETS
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
DMLP
DMLP
PETS
PETS
Q4 25
-25.7%
Q3 25
-18.9%
Q2 25
-66.7%
Q1 25
-11.9%
Q4 24
-0.9%
Q3 24
1.0%
Q2 24
6.6%
Q1 24
-5.9%
Net Margin
DMLP
DMLP
PETS
PETS
Q4 25
38.7%
-26.0%
Q3 25
31.5%
-19.2%
Q2 25
38.1%
-66.7%
Q1 25
40.9%
-22.9%
Q4 24
35.9%
-1.4%
Q3 24
68.1%
4.0%
Q2 24
63.2%
5.7%
Q1 24
58.6%
-7.7%
EPS (diluted)
DMLP
DMLP
PETS
PETS
Q4 25
$-0.50
Q3 25
$-0.41
Q2 25
$-1.65
Q1 25
$-0.56
Q4 24
$-0.03
Q3 24
$0.11
Q2 24
$0.18
Q1 24
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DMLP
DMLP
PETS
PETS
Cash + ST InvestmentsLiquidity on hand
$41.9M
$26.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.8M
Total Assets
$309.6M
$88.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DMLP
DMLP
PETS
PETS
Q4 25
$41.9M
$26.9M
Q3 25
$41.6M
$36.1M
Q2 25
$36.5M
$41.1M
Q1 25
$41.5M
$54.7M
Q4 24
$42.5M
$50.1M
Q3 24
$56.5M
$52.0M
Q2 24
$35.2M
$46.0M
Q1 24
$37.7M
$55.3M
Stockholders' Equity
DMLP
DMLP
PETS
PETS
Q4 25
$32.8M
Q3 25
$43.1M
Q2 25
$51.5M
Q1 25
$85.1M
Q4 24
$96.2M
Q3 24
$96.4M
Q2 24
$93.5M
Q1 24
$96.7M
Total Assets
DMLP
DMLP
PETS
PETS
Q4 25
$309.6M
$88.0M
Q3 25
$330.4M
$100.3M
Q2 25
$325.6M
$109.8M
Q1 25
$349.0M
$148.7M
Q4 24
$366.8M
$144.8M
Q3 24
$403.4M
$146.0M
Q2 24
$176.0M
$152.7M
Q1 24
$184.8M
$169.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DMLP
DMLP
PETS
PETS
Operating Cash FlowLast quarter
$34.3M
$-9.2M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-22.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
2.12×
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DMLP
DMLP
PETS
PETS
Q4 25
$34.3M
$-9.2M
Q3 25
$34.3M
$-2.2M
Q2 25
$30.5M
$-12.3M
Q1 25
$33.4M
$7.0M
Q4 24
$31.5M
$-1.2M
Q3 24
$43.7M
$7.4M
Q2 24
$29.4M
$-8.5M
Q1 24
$28.0M
$7.1M
Free Cash Flow
DMLP
DMLP
PETS
PETS
Q4 25
$-9.2M
Q3 25
$-4.8M
Q2 25
$-13.6M
Q1 25
$4.6M
Q4 24
$-1.9M
Q3 24
$6.1M
Q2 24
$-9.2M
Q1 24
$5.9M
FCF Margin
DMLP
DMLP
PETS
PETS
Q4 25
-22.7%
Q3 25
-10.8%
Q2 25
-26.5%
Q1 25
9.1%
Q4 24
-3.7%
Q3 24
10.6%
Q2 24
-13.9%
Q1 24
9.0%
Capex Intensity
DMLP
DMLP
PETS
PETS
Q4 25
0.1%
Q3 25
5.9%
Q2 25
2.5%
Q1 25
4.7%
Q4 24
1.5%
Q3 24
2.2%
Q2 24
1.0%
Q1 24
1.9%
Cash Conversion
DMLP
DMLP
PETS
PETS
Q4 25
2.12×
Q3 25
3.07×
Q2 25
2.47×
Q1 25
1.89×
Q4 24
2.21×
Q3 24
1.20×
3.18×
Q2 24
1.25×
-2.27×
Q1 24
1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DMLP
DMLP

Royalties$34.0M81%
Other$7.8M19%

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

Related Comparisons